Conavi Medical Corp. announced the pricing of its public offering of common shares and/or pre-funded warrants, aiming to raise between $10 million and $15 million. The offering price is set at $0.20 per common share or $0.19999 per pre-funded warrant. Proceeds will be used to support a limited market release in the United States, as well as for working capital and general corporate purposes. The offering is expected to close around August 5, 2026, subject to regulatory approvals and customary conditions.
MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...
Rambus, a specialist in memory interface chips, is positioned for significant growth with its technology embedded in next-gen server memory modules like DDR5 and HBM4E. The company reported strong Q2 2026 results with 20.4% revenue growth and expects...
DraftKings CEO Jason Robins highlighted strong early NFL season performance with a 15% increase in handle growth and renewed iGaming market share gains. The company remains on track to achieve about $1 billion in adjusted EBITDA for 2026, with expect...
Elemental Royalty Corporation announced the acquisition of a portfolio including 3 streams and 5 royalties, all in precious metals, significantly expanding its asset base. This deal adds approximately 5,000 gold equivalent ounces immediately and will...
Coinbase has introduced fixed-rate crypto-backed loans through Morpho Midnight, allowing users to borrow USDC against Bitcoin with locked interest rates and repayment dates. This new option complements Coinbase's existing variable-rate loans powered ...
